Paper Review Records
All Paper Review Records
18 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
98
days
Progress Towards Eliminating Hepatitis C as a Public Health Threat in Norway
AuthorsRobert Whittaker; Linda Couëssurel Wüsthoff; Jørgen Eriksson Midtbø; Håvard Midgard; Olav Dalgard
Affiliations1. Department of Infection Control and Vaccines Norwegian Institute of Public Health Oslo Norway; 2. Unit for Clinical Research on Addictions Oslo University Hospital Oslo Norway; 3. Norwegian Centre for Addiction Research University of Oslo Oslo Norway; 4. Department of Method Development and Analytics Norwegian Institute of Public Health Oslo Norway; 5. Department of Gastroenterology Oslo University Hospital Oslo Norway; 6. Institute of Clinical Medicine University of Oslo Oslo Norway; 7. Department of Infectious Diseases Akershus University Hospital Lørenskog Norway
347
days
A Novel Quantitative ELISA Demonstrates Lack of Correlation Between Serum HDV ‐ RNA and Anti‐ HDV Antibody Levels in Chronic HDV Infection
AuthorsNomin Ariungerel; Khaliunaa Otgonbaatar; Saruul Enkhjargal; Ulziigerel Erdembileg; Sumiya Byambabaatar; Badmaarag Munkhjin; Tuul Tsagaantsooj; Sanjaasuren Enkhtaivan; Byambasuren Ochirsum; Purevjargal Bat‐Ulzii; Enkhnomin Ochirbat; Naranjargal Dashdorj; Odgerel Oidovsambuu
Affiliations1. Department of Chemical and Biological Engineering National University of Mongolia Ulaanbaatar Mongolia; 2. The Liver Center Ulaanbaatar Mongolia; 3. Mongolian National University of Medical Sciences Ulaanbaatar Mongolia
222
days
ALG ‐020572, an Antisense Oligonucleotide for the Treatment of Chronic Hepatitis B Virus Infection Discontinued for Drug‐Induced Liver Injury
AuthorsKosh Agarwal; Dan Forton; Yoh Zen; Min Wu; Tse‐I Lin; Kha Le; Sushmita Chanda; Lawrence Blatt; John Fry; Ed Gane
Affiliations1. Institute of Liver Studies King's College Hospital London UK; 2. NIHR St. George's Clinical Research Facility St. George's University Hospitals London UK; 3. Aligos Therapeutics, Inc. San Francisco California USA; 4. Aligos Belgium BV Mechelen Belgium; 5. University of Auckland Auckland New Zealand
100
days
Virologic Response to Antiviral Therapy in Chronic Hepatitis B Patients With High Viral Load: A Real‐World Cohort Study
AuthorsSiwei Zheng; Xueyan Li; Hongli Liu; Tianhao Mao; You Ge; Wenjing Ji; Xixuan Wang; Yijun Bao; Yu Zhang; Anling Zhou; Qunzeng Danzeng; Jialuo Wang; Feng Yang; Qingfang Xiong; Yongfeng Yang
Affiliations1. Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing Clinical Teaching Hospital of Medical School, Nanjing University Nanjing China; 2. Department of Infectious Disease and Liver Disease The Second Hospital of Nanjing, Affiliated to Nanjing University of Chinese Medicine Nanjing China; 3. Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing Teaching Hospital of Southeast University Nanjing China; 4. Department of Infectious Disease and Liver Disease The Second Hospital of Nanjing, The Affiliated Nanjing No. 2 Clinical College of Xuzhou Medical University Nanjing China; 5. Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing Teaching Hospital, Nanjing Medical University School of Public Health Nanjing China
70
days
Peripheral Biomarkers in Chronic Hepatitis D Infection: A Review
AuthorsZillah Cargill; James Lok; Geoffrey Dusheiko; Ivana Carey
Affiliations1. Institute of Liver Studies Kings College Hospital London UK; 2. Kings College London London UK
176
days
A New Nomogram for Mortality Prediction Within 5 Years in Portal Vein Thrombosis due to Hepatitis B‐Related Cirrhosis
AuthorsYang Zhou; Feixiang Xiong; Jialiang Chen; Xiaoli Liu; Peipei Meng; Tong Wu; Hao Yu; Xiaomin Ji; Yuyong Jiang; Yixin Hou
Affiliations1. Center of Integrative Medicine, Department of Integrated Traditional Chinese and Western Medicine II Beijing Ditan Hospital, Capital Medical University Beijing China
300
days
Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta‐Analysis
AuthorsCarolyn Wallace; Devin Razavi‐Shearer; Samantha Hall; Tarik Asselah; Cary James; Loreta A. Kondili; Shyamasundaran Kottilil; Daniel Low‐Beer; Poonam Mathur; Junko Tanaka; Harrys A. Torres; Homie Razavi
Affiliations1. Center for Disease Analysis Foundation Lafayette Colorado USA; 2. Department of Hepatology Université de Paris‐Cité, Hôpital Beaujon, Assistance Publique‐Hôpitaux de Paris, INSERM Unité Mixte de Recherche 1149 Clichy France; 3. World Hepatitis Alliance Geneva Switzerland; 4. National Center for Global Health, Istituto Superiore di Sanita Rome Italy; 5. UniCamillus‐Saint Camillus International University of Health Sciences Rome Italy; 6. Institute of Human Virology University of Maryland School of Medicine Baltimore Maryland USA; 7. Global HIV, Hepatitis and Sexually Transmitted Infections Programmes World Health Organization Geneva Switzerland; 8. Department of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University Hiroshima City Hiroshima Japan; 9. Department of Infectious Diseases, Infection Control and Employee Health The University of Texas MD Anderson Cancer Center Houston Texas USA; 10. Department of Gastroenterology, Hepatology and Nutrition The University of Texas MD Anderson Cancer Center Houston Texas USA
126
days
Geospatial Discrepancy of Chronic Hepatitis B and Hepatitis D Testing in Alberta: A Population‐Based Spatial Analysis
AuthorsBryce Tkachuk; Isabelle Couloigner; Carla S. Coffin; Jason Jiang; Stefania Bertazzon; Abdel‐Aziz Shaheen
Affiliations1. Division of Gastroenterology and Hepatology, Department of Medicine Cumming, School of Medicine, University of Calgary Calgary Alberta Canada; 2. Department of Geography University of Calgary Calgary Alberta Canada; 3. Provincial Research Data Services, Health Shared Services Calgary Alberta Canada
91
days
Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review
AuthorsEmma Victoria Shiel; Bini George; Arpana Verma; Norina Gasteiger
Affiliations1. Mental Health Research Group, Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine, and Health University of Manchester Manchester UK; 2. Manchester University NHS Foundation Trust Manchester UK; 3. School of Medical Sciences, Faculty of Biology, Medicine, and Health University of Manchester Manchester UK; 4. Division of Nursing, Midwifery and Social Work, Faculty of Biology, Medicine, and Health University of Manchester Manchester UK
84
days
Characterising Hepatitis D Virus in the UK From 2011 to 2021
AuthorsR. Simmons; S. Ijaz; R. Jackson; K. Jack; R. Mulongeni; R. Raghu; A. Riddell; A. Elsharkawy; A. Uriel; A. Koffas; A. Chaika; A. Lawson; A. Cole; A. McEwan; A. Brown; B. Stone; C. Levick; D. Byrne; D. Forton; D. MacDonald; D. Forde; E. Nastouli; E. Barnes; E. Sumner; E. Page; I. Carey; F. J. Vilar; J. Maggs; J. Collier; J. Shepherd; K. Agarwal; K. Bicknell; K. Ala; K. Dear; L. Ratcliffe; M. Bruce; H. Zhang; L. Rivett; M. Maes; M. Ankcorn; M. Aldersley; M. Prince; M. Lemoine; M. Foxton; M. Wright; M. Cramp; M. Wiselka; N. Easom; P. Richardson; R. Gunson; R. Herbert; R. Blackwell; R. Jelley; R. Aspinall; R. Simpson; R. Clewes; S. Ahmad; S. Mcpherson; S. Ryder; S. Verma; T. Lampejo; V. Sathyanarayana; W. Gelson; D. Leeman; M. Desai; S. Mandal; P. T. Kennedy; W. L. Irving
Affiliations1. UK Health Security Agency London UK; 2. Nottingham University Hospitals NHS Trust Nottingham UK; 3. Barts Health NHS Trust London UK; 4. NIHR Biomedical Research Centre at University Hospitals Birmingham NHS Foundation Trust Birmingham UK; 5. University Hospitals Birmingham NHS Foundation Trust Birmingham UK; 6. Manchester University NHS Foundation Trust Manchester UK; 7. University Hospitals of Derby and Burton NHS Foundation Trust Derby UK; 8. Imperial College Healthcare NHS Trust London UK; 9. Sheffield Teaching Hospitals NHS Foundation Trust Sheffield UK; 10. Royal Devon and Exeter NHS Foundation Trust Exeter UK; 11. Liverpool University Hospitals NHS Foundation Trust Liverpool UK; 12. St George's University Hospitals NHS Foundation Trust London UK; 13. Royal Free London NHS Foundation Trust London UK; 14. Public Health Wales Cardiff UK; 15. University College London Hospital NHS Foundation Trust London UK; 16. Oxford University Hospitals NHS Foundation Trust Oxford UK; 17. Nuffield Department of Medicine University of Oxford Oxford UK; 18. Micropathology Ltd Coventry UK; 19. Leeds Teaching Hospitals NHS Trust Leeds UK; 20. Institute of Liver Studies Kings College Hospital London UK; 21. Buckinghamshire Healthcare NHS Trust Aylesbury UK; 22. The Lothian University Hospitals NHS Trust Edinburgh UK; 23. Portsmouth Hospitals University NHS Trust Portsmouth UK; 24. Hampshire Hospitals NHS Foundation Trust Basingstoke UK; 25. Chesterfield Royal Hospital NHS Foundation Trust Chesterfield UK; 26. Cambridge University Hospitals NHS Foundation Trust Cambridge UK; 27. University Hospital Southampton NHS Foundation Trust Southampton UK; 28. University Hospitals Plymouth NHS Trust Plymouth UK; 29. University Hospitals of Leicester NHS Trust Leicester UK; 30. Hull University Teaching Hospitals NHS Trust Kingston upon Hull UK; 31. West of Scotland Specialist Virology Centre Gartnavel General Hospital Glasgow UK; 32. Liver Unit and NIHR Biomedical Research Centre, Newcastle Upon Tyne Hospitals NHS Foundation Trust and Translational & Clinical Research Institute Newcastle University Newcastle upon Tyne UK; 33. NIHR Nottingham Biomedical Research Centre at Nottingham University Hospitals NHS Trust Nottingham UK; 34. Department of Clinical and Experimental Medicine, Brighton & Sussex Medical School University of Brighton and University of Sussex Brighton UK; 35. Department of Gastroenterology and Hepatology (Digestive Diseases), Royal Sussex County Hospital University Hospitals Sussex NHS Foundation Trust Brighton UK; 36. Barnsley Hospital NHS Foundation Trust Barnsley UK; 37. Queen Mary University of London London UK
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days